# The STRIVE Study: Development of a Blood Test for Early Detection of Multiple Cancer Types

> **NCT03085888** · — · COMPLETED · sponsor: **GRAIL, Inc.** · enrollment: 99481 (actual)

## Conditions studied

- Neoplasms
- Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03085888
- **Lead sponsor:** GRAIL, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-28
- **Primary completion:** 2022-06-30
- **Final completion:** 2024-04-01
- **Target enrollment:** 99481 (ACTUAL)
- **Last updated:** 2024-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03085888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03085888, "The STRIVE Study: Development of a Blood Test for Early Detection of Multiple Cancer Types". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT03085888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*